Latest News

This Canadian battery company is quietly putting up numbers that most investors haven't noticed yet.

Tesla's Semi is generating serious interest, backed by impressive results -- and potential customers are taking notice.

The company is already renowned by many as a giant in the segment.

Moderna just received fantastic news.

The impact of the closure of the Strait of Hormuz won't be short-term, even if it's reopened in 2026.

Today, June 22, 2026, traders weighed peace talk progress against interest rate concerns and ETF outflows.

Apple effectively confirmed that the memory shortage doesn't appear to be ending anytime soon.

On June 22, 2026, Apogee Therapeutics shares surged as investors reacted to AbbVie's proposed acquisition terms.

Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their fundamentals stack up for investors.

UiPath is giving enterprises more ways to coordinate AI agents, robots, and people, with the next readout focused on whether agentic automation demand can lift recurring revenue and customer expansion.

SpaceX stock fell Monday, losing the combined value of Palantir and Robinhood.

Alphabet has the scale to fund AI, with investors looking for Gemini, Google Cloud, and Search to turn that spending into measurable growth as talent concerns intensify.

SpaceX isn't likely to generate the mammoth returns that Tesla has since going public.

Today, June 22, 2026, Super Micro Computer shares soared as investors responded to AI optimism.

Manulife Financial (NYSE:MFC) has outperformed the market over the past 5 years by 3.26% on an annualized basis producing an average annual ...

On June 22, 2026, investors rotated into blue chips as easing oil prices and diplomatic progress shaped market sentiment, today.

Long-term investors should skip the SpaceX roller coaster, and pivot toward these three Dividend Kings instead.

Accelerating AI chip demand may give this top chip stock a second wind.

Trip.com Group (NASDAQ:TCOM) has outperformed the market over the past 20 years by 1.3% on an annualized basis producing an average annual ...

Elon Musk became the world's first trillionaire when SpaceX went public. His net worth is dropping as SpaceX shares sell off.

It's expanding its scope of services for GLP-1 obesity medications.

Barclays (NYSE:BCS) has outperformed the market over the past 5 years by 10.73% on an annualized basis producing an average annual return ...

Given their strong financial performance and compelling growth prospects, these two Canadian stocks present attractive buying opportunities for long-term investors.

This is a solid high-yield stock for a long-term buy and hold, especially on market corrections.

Sector weights and risk profiles differ sharply between these two funds, shaping their appeal for different investor priorities.